Cyprazepam

This classification denotes a benzodiazepine with the molecular formula C19H18ClN3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 933N61G4SL, chemically known as 7-chloro-2-((cyclopropylmethyl)amino)-5-phenyl-3h-1,4-benzodiazepine 4-oxide but generally known as cyprazepam, which bears US NIH Compound Identifier 27452. European Medicines Agency schedules Cyprazepam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06872MIG. The term CYPRAZEPAM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 21 No. 12 1967, List 7). Most nations schedule cyprazepam under HS 29339940 and SITC 51577. As of Q4 2014, CYPRAZEPAM remains the US FDA Preferred Term for this commodity. Cyprazepam bears US NLM identifiers UMLS ID C2699536 and NCI Concept Code C76534. SMILES: CLC1CC2=C(N(O)CC(=N\CC3CC3)\N=C2CC1)C1CCCCC1.